Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > East/South/London

Find below news from East of England, South West of England, South East of England and Greater London. Listed are news about these regions as well as from organisations located there.

Total search results: 1769 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Medigene AG. (2/11/19). "Press Release: Medigene Appoints Axel-Sven Malkomes as CFO/CBDO". Martinsried. 2019-02-11
Sygnature Discovery Ltd.. (2/7/19). "Press Release: Pathios Therapeutics and Sygnature Discovery Sign a Strategic and Innovative Partnership to Develop First in Class Therapies in Autoimmune Disease and Immuno-oncology". Oxford & Nottingham. 2019-02-07
Rewind Therapeutics. (2/6/19). "Press Release: Rewind Therapeutics Expands Scientific Advisory Board with Addition of Professors Robin Franklin and Catherine Lubetzki, Bringing further Expertise in Myelin and Multiple Sclerosis Research". Leuven. 2019-02-06
4SC AG. (2/6/19). "Press Release: First Patient Enrolled in Phase II Study EMERGE of Domatinostat (4SC-202) in Gastrointestinal Cancer". Planegg-Martinsried. 2019-02-06
Sosei Group Corporation (d/b/a Sosei Heptares). (2/4/19). "Press Release: Sosei Heptares Announces Medicxi to Invest up to €40 Million in New Collaboration Based on Its Orexin Agonist Program". Tokyo & London. 2019-02-04
Avacta Group plc. (2/4/19). "Press Release: Moderna Exercises Option for an Exclusive Product License". 2019-02-04
MeiraGTx Holdings plc. (1/31/19). "Press Release: MeiraGTx Enters into Strategic Collaboration with Janssen to Develop and Commercialize Gene Therapy Treatments for Inherited Retinal Diseases". London & New York, NY. 2019-01-31
Optibrium Ltd.. (1/28/19). "Press Release: Optibrium Strengthens Senior Management Team with Financial Director Appointment". Cambridge. 2019-01-28
Horizon Discovery Group plc. (1/28/19). "Press Release: Horizon Discovery and Rutgers University Form Exclusive Partnership to Develop Next Generation Novel Gene Editing Technology". Cambridge. 2019-01-28
Wren Therapeutics Ltd.. (1/22/19). "Press Release: Wren Therapeutics Completes £18 Million Series A Financing". Cambridge. 2019-01-22
Novo Holdings A/S. (1/21/19). "Press Release: Novo Holdings Announces New Investments by REPAIR Impact Fund. Four Investments Nade in First Year, Totalling €18 Million". Copenhagen. 2019-01-21
Autifony Therapeutics Ltd.. (1/18/19). "Press Release: Autifony Therapeutics Achieves First Milestone in Agreement with Boehringer Ingelheim for a Novel Therapeutic Approach to a Range of CNS Disorders". Stevenage. 2019-01-18
Immunocore Ltd.. (1/15/19). "Press Release: Immunocore Names David Berman as Head of R&D". Oxford & Conshohocken, PA. 2019-01-15
Phico Therapeutics Ltd.. (1/15/19). "Press Release: Phico Therapeutics Appoints Financial Director and Two Non-Executives". Cambridge. 2019-01-15
Deyton Bell Ltd.. (1/13/19). "Press Release: Deyton Bell Announce Exciting Further Expansion – Harriet Fear Joins the Team". 2019-01-13
Orchard Therapeutics Ltd.. (1/7/19). "Press Release: Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene Therapy". Boston & London. 2019-01-07
Aptamer Group Ltd.. (1/7/19). "Press Release: Aptamer Group Announces Agreement with AstraZeneca to Explore Next-Generation Drug Delivery Devices". 2019-01-07
AstraZeneca plc. (1/7/19). "Press Release: AstraZeneca Announces Organisational Changes". 2019-01-07
Sophia Genetics S.A.. (1/4/19). "Press Release: Sophia Genetics Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine". San Francisco, CA. 2019-01-04
Morphogen-IX Ltd.. (12/20/18). "Press Release: Morphogen-IX Raises £18.4M ($23.2M) in a Series B Financing". Cambridge. 2018-12-20
Orchard Therapeutics Ltd.. (12/14/18). "Press Release: Orchard Therapeutics and Sirion Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency". Boston, London & Martinsried. 2018-12-14
Orchard Therapeutics Ltd.. (12/13/18). "Press Release: Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California". Boston, MA & London. 2018-12-13
Synthace Ltd.. (12/12/18). "Press Release: Computer Aided Biology Pioneer Synthace Secures $25.6 Million in Series B Funding". London. 2018-12-12
Arix Bioscience plc. (12/11/18). "Press Release: Arix Appoints Dr Christian Schetter as Entrepreneur In Residence (EIR)". London. 2018-12-11
Alnylam Pharmaceuticals, Inc.. (12/10/18). "Press Release: Alnylam Announces Settlement of Litigation with Silence Therapeutics". Cambridge, MA. 2018-12-10
AstraZeneca plc. (12/10/18). "Press Release: AstraZeneca and Cancer Research UK Launch Functional Genomics Centre to Accelerate the Discovery of New Medicines". 2018-12-10
AstraZeneca plc. (12/7/18). "Press Release: Update on the Phase III EAGLE Trial of Imfinzi and Tremelimumab in Advanced Head and Neck Cancer". 2018-12-07
Igem Therapeutics Ltd.. (11/30/18). "Press Release: Igem Therapeutics Announces Final Close of £5 Million Series A Financing Round". London. 2018-11-30
AbCellera Biologics, Inc.. (11/29/18). "Press Release: AbCellera Collaborates with Autolus on Antibody Discovery Project". Vancouver, BC. 2018-11-29
Biocartis Group N.V.. (11/29/18). "Press Release: Biocartis and AstraZeneca Enter into Agreement Aimed at Faster Lung Cancer Biomarker Results". Mechelen. 2018-11-29
OMass Therapeutics Ltd.. (11/27/18). "Press Release: OMass Therapeutics Expands Its Senior Leadership Team". 2018-11-27
BRAIN AG. (11/26/18). "Press Release: Suntory Beverage & Food Europe and BRAIN AG Start Joint Development Program". Zwingenberg & Uxbridge. 2018-11-26
Immune Regulation Ltd.. (11/26/18). "Press Release: Immune Regulation Announces Positive Results from Phase 1 Clinical Trial of PIN201104". Stevenage. 2018-11-26
GlaxoSmithKline plc. (11/26/18). "Press Release: Juluca (dolutegravir/rilpivirine), the First Single Pill, 2-drug Regimen, for the Maintenance Treatment of HIV, Granted Marketing Approval by Japan Ministry of Health, Labour and Welfare". London. 2018-11-26
Cobra Biologics Ltd.. (11/26/18). "Press Release: Cobra Biologics, Pall Corporation and the Cell and Gene Therapy Catapult Win £1.5M Innovate UK Grant to Investigate Continuous Manufacturing for Gene Therapies". Keele & Port Washington, NY & London. 2018-11-26
Fluidic Analytics Ltd.. (11/26/18). "Press Release: Fluidic Analytics Raises $31m to Launch Two New Products in Lab Tools Pipeline and Unlock Biology Behind Major Diseases". 2018-11-26
Immune Regulation Ltd.. (11/22/18). "Press Release: Peptinnovate Announces Change of Name to Immune Regulation, Strengthening of the Board and Successful Fundraise". 2018-11-22
OMass Therapeutics Ltd.. (11/21/18). "Press Release: OMass Therapeutics Announces £14 Million Series A Financing to Build a Pipeline of Proprietary Medicines". Oxford. 2018-11-21
Celyad S.A.. (11/21/18). "Press Release: Celyad Announces Third Quarter 2018 Business Update". Mont-Saint-Guibert. 2018-11-21
Goodwin Procter LLC. (11/15/18). "Press Release: Goodwin Adds Life Sciences and Technology Partner Sophie McGrath in London". London. 2018-11-15
Virion Biotherapeutics Ltd.. (11/14/18). "Press Release: Virion Biotherapeutics Demonstrates Preclinical Proof-of-Concept for First Therapeutic Interfering Particle Candidate in Respiratory Virus Infections". London. 2018-11-14
Hox Therapeutics Ltd.. (11/13/18). "Press Release: Hox Therapeutics Appoints Karl Keegan as Chief Executive Officer". Guildford, Surrey. 2018-11-13
Consilium Strategic Communications Ltd.. (11/12/18). "Press Release: Alex Harrison Joins Consilium Strategic Communications". London. 2018-11-12
Sygnature Discovery Ltd.. (11/8/18). "Press Release: Sygnature Discovery Announces Multi-target Drug Discovery Deal with Sitryx Therapeutics". 2018-11-08
AstraZeneca plc. (11/6/18). "Press Release: Divestment of Rights to Alvesco, Omnaris and Zetonna to Covis Pharma". 2018-11-06
Orchard Therapeutics Ltd.. (11/5/18). "Press Release: Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including the Partial Exercise of Underwriters’ Option". Boston, MA & London. 2018-11-05
Grünenthal GmbH. (10/30/18). "Press Release: Grünenthal Agrees US$ 922 m Deal with AstraZeneca for Nexium and Vimovo". Aachen. 2018-10-30
DefiniGen Ltd.. (10/30/18). "Press Release: DefiniGen Licenses Broad Institute CRISPR-Cas9 Gene Editing Technology for Optimized Metabolic Disease Drug Development". Cambridge. 2018-10-30
Immunocore Ltd.. (10/26/18). "Press Release: Immunocore CEO Andrew Hotchkiss Appointed to the Board of the BIA". Oxford & Conshohocken, PA. 2018-10-26
MeiraGTx Holdings plc. (10/25/18). "Press Release: MeiraGTx Expands Leadership Team with Appointment of Katherine Breedis as Chief Financial Officer". London & New York, NY. 2018-10-25
Microbiotica Ltd.. (10/24/18). "Press Release: Microbiotica Attracts Equity Investment from Seventure’s Health for Life Capital Fund". Cambridge. 2018-10-24
NodThera Ltd.. (10/23/18). "Press Release: NodThera Announces the Appointment of Alison Strutt PhD as Head of Finance & Operations, the Launch of Its New Corporate Office in Boston and the Opening of Its Laboratory in Seattle". Cambridge, Boston, MA & Se 2018-10-23
Innate Pharma S.A.. (10/23/18). "Press Release: Innate Pharma Strengthens and Expands Its Oncology Development Collaboration with AstraZeneca". Marseille. 2018-10-23
Medicines Discovery Catapult, The. (10/22/18). "Press Release: Overcoming Bottlenecks in Early Drug Discovery with the Power of Sound. Medicines Discovery Catapult and AstraZeneca Collaborate to Unlock the Potential of Acoustic Mist Ionisation Mass Spect 2018-10-22
Amgen Inc.. (10/18/18). "Press Release: Amgen Invests £50 Million ($66 Million) in Oxford Nanopore Technologies". Thousand Oaks, CA & Oxford. 2018-10-18
MeiraGTx Holdings plc. (10/16/18). "Press Release: MeiraGTx Enters Collaboration with Johnson & Johnson Innovation to Develop Regulatable Gene Therapy Treatment using MeiraGTx Riboswitch Technology". London & New York, NY. 2018-10-16
Genedata AG. (10/16/18). "Press Release: Deep Learning-based Genedata Imagence for Automated High-Content Image Analysis Debuts at SLAS Conference". Basel. 2018-10-16
F-Star Biotechnology Ltd.. (10/15/18). "Press Release: F-star Appoints Dr Eliot Forster as Chief Executive Officer". Cambridge. 2018-10-15
Owlstone Medical. (10/10/18). "Press Release: Owlstone Medical Appoints Dr Richard A Yost to Scientific Advisory Board". Cambridge. 2018-10-10
Hummingbird Diagnostics GmbH. (10/9/18). "Press Release: Jörg Debatin to Chair the Supervisory Board of Hummingbird Diagnostics GmbH". Heidelberg & Boston, MA. 2018-10-09
MeiraGTx Holdings plc. (10/9/18). "Press Release: MeiraGTx Announces Acquisition of Vector Neurosciences, Gains Phase 2 Gene Therapy Program for Parkinson’s Disease". London & New York. 2018-10-09
Sitryx Therapeutics Ltd.. (10/8/18). "Press Release: New Biopharmaceutical Company Sitryx Launches with $30 Million Fundraising to Develop Disease Modifying Therapeutics in Immunometabolism". Oxford. 2018-10-08
Bluebird Bio, Inc.. (10/5/18). "Press Release: Bluebird Bio Announces European Medicines Agency’s Acceptance of Marketing Authorization Application for LentiGlobin Gene Therapy for the Treatment of Transfusion-Dependent ß-Thalassemia". Cambridge, MA. 2018-10-05
Celyad S.A.. (10/4/18). "Press Release: Celyad Announces Exclusive Agreement for Horizon Discovery’s shRNA Platform to Develop NextGeneration Allogeneic CAR-T Therapies". Mont-Saint-Guibert. 2018-10-04
Taros Chemicals GmbH & Co. KG. (10/1/18). "Press Release: Taros Appoints Torsten Hoffmann as Senior Vice President Drug Discovery". Dortmund. 2018-10-01
Evonetix Ltd.. (10/1/18). "Press Release: Evonetix Partner with LioniX International to Enable DNA Synthesis at Scale". Cambridge & Enschede. 2018-10-01
Owlstone Medical Ltd.. (10/1/18). "Press Release: Owlstone Medical Completes $50 Million USD (c.£38 Million GBP) Financing Round". Cambridge. 2018-10-01
Arix Bioscience plc. (10/1/18). "Press Release: Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio". London. 2018-10-01
Tusk Therapeutics Ltd.. (9/28/18). "Press Release: Tusk Therapeutics to Be Acquired by Roche". Stevenage. 2018-09-28
Nightstar Therapeutics plc. (9/27/18). "Press Release: Nightstar Announces Pricing of Public Offering". Waltham, MA & London. 2018-09-27
TTP Labtech Ltd.. (9/27/18). "Press Release: Battery Ventures Acquires TTP Labtech Limited, Global Leader in Liquid Handling & Sample Management Technologies". Cambridge. 2018-09-27
Novacyt S.A.. (9/26/18). "Press Release: Novacyt Half Year 2018 Results. Molecular Product Revenues up 18% to €3m – Gross Margin Increases to 64%". Paris & Camberley. 2018-09-26
Nightstar Therapeutics plc. (9/25/18). "Press Release: Nightstar Announces Proposed Public Offering of American Depositary Shares". Waltham, MA & London. 2018-09-25
Thermo Fisher Scientific Inc.. (9/24/18). "Press Release: New Single Quadrupole Mass Spectrometry Technology Designed for Chromatographers Performing LC-MS Routine Analysis". Cannes-Mandelieu. 2018-09-24
NodThera Ltd.. (9/24/18). "Press Release: NodThera Announces the Appointment of Adam Keeney PhD as President and Chief Executive Officer". Cambridge & Boston, MA. 2018-09-24
Addex Therapeutics S.A.. (9/20/18). "Press Release: Addex ADX10061 Receives £1.2 million Funding for Manufacture and Investigator Led Clinical Studies as Part of the Tools for Human Drug and Brain Research (THuNDR2) Initiative from the Wellcome Trust". G 2018-09-20
Domainex Ltd.. (9/20/18). "Press Release: Domainex Appoints Dr Trevor Perrior as Chief Executive Officer". Cambridge. 2018-09-20
Medicines Discovery Catapult, The. (9/19/18). "Press Release: Novel Deep Learning Drug Discovery Platform Gets £1 Million Innovation boost. Optibrium, Intellegens and Medicines Discovery Catapult Awarded Funding to Apply Machine Learning in Drug Discover 2018-09-19
Metrion Biosciences Ltd.. (9/17/18). "Press Release: Metrion Biosciences Makes Senior Appointments to Strengthen Its Drug Discovery Leadership tTeam". Cambridge. 2018-09-17
Sphere Fluidics Ltd.. (9/17/18). "Press Release: Sphere Fluidics Introduces New Cyto-Mine Studio Software Suite". Cambridge. 2018-09-17
Cancer Research UK. (9/17/18). "Press Release: London Biotherapeutics Powerhouse Launched by Cancer Research UK". 2018-09-17
BIA Separations d.o.o.. (9/17/18). "Press Release: BIA Separations Expands with New Upstream Processing Facility". Ajdovšcina. 2018-09-17
Horizon Discovery Group plc. (9/14/18). "Press Release: Horizon Discovery Edit-R crRNA Libraries Adopted by AstraZeneca as Part of Its Functional Genomics Discovery Platform". Cambridge. 2018-09-14
University of Oxford. (9/12/18). "Press Release: Novo Nordisk Research Centre Opens in Oxford". 2018-09-12
Arix Bioscience plc. (9/12/18). "Press Release: Arix Bioscience plc Announces Board Changes, Appointment of Arthur Pappas to the Board of Directors, David U’Prichard to Retire from Board". London. 2018-09-12
Crescendo Biologics Ltd.. (9/11/18). "Press Release: Crescendo Biologics Strengthens its Management with the Appointment of Dr Pavel Pisa as Chief Medical Officer". Cambridge. 2018-09-11
Optibrium Ltd.. (9/11/18). "Press Release: Optibrium and Intellegens Collaborate to Apply Novel Deep Learning Methods to Drug Discovery". Cambridge. 2018-09-11
University of Glasgow. (9/11/18). "Press Release: Cutting-edge Electron Microscope Revealed at Opening of New £5m Structural Biology Centre". 2018-09-11
Cell and Gene Therapy Catapult, The. (9/11/18). "Press Release: Stevenage Cell and Gene Therapy Catapult Centre Gets Green Light to Make New Cell and Gene Therapies". 2018-09-11
Arecor Ltd.. (9/10/18). "Press Release: Arecor Secures £6m Investment for the Clinical Development of Its Diabetes Speciality Pharma Portfolio". Cambridge. 2018-09-10
F-Star Biotechnology Ltd.. (9/10/18). "Press Release: F-star Appoints Nessan Bermingham as Chairman of its Board of Directors". Cambridge. 2018-09-10
BTG plc. (9/7/18). "Press Release: BTG plc Acquires Novate Medical Ltd.". 2018-09-07
Adaptimmune Therapeutics plc. (9/5/18). "Press Release: Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares". Philadeliphia, PA & Oxford. 2018-09-05
Azeria Therapeutics Ltd.. (9/4/18). "Press Release: Azeria Therapeutics, the World's First Pioneer Factor Drug Discovery Company, Announces Series A Investment from Sixth Element Capital". Cambridge. 2018-09-04
Optibrium Ltd.. (9/4/18). "Press Release: Optibrium and Enamine Collaboration Extends Commercial Compound Database Access for StarDrop Users". Cambridge & Kiev. 2018-09-04
Arix Bioscience plc. (9/4/18). "Press Release: Changes Announced to Executive Team to Accelerate Growth and Strategy". London. 2018-09-04
Genomics plc. (8/30/18). "Press Release: Genomics plc Raises £25 million in Series B Round to Advance Its Use of Human Genetics and Data Science in Drug Discovery". Oxford. 2018-08-30
Genomics Medicine Ireland Ltd.. (8/30/18). "Press Release: Genomics Medicine Ireland and University of Cambridge Announce Multiple Sclerosis Research Collaboration". Dublin. 2018-08-30
Kandy Therapeutics Ltd.. (8/29/18). "Press Release: Kandy Therapeutics Successfully Raises £25 Million in a Series C Financing". Stevenage. 2018-08-29
Orchard Therapeutics Ltd.. (8/29/18). "Press Release: Orchard Therapeutics Expands Leadership Team with Appointments of Head of Corporate Communications and Head of Human Resources". Boston, MA & London. 2018-08-29
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture BIO Deutschland German Biotech Days 2019 Würzburg 600x60px

» top